tailieunhanh - báo cáo hóa học: " Reliability of a 1-week recall period for the Medical Outcomes Study Sleep Scale (MOS-SS) in patients with fibromyalgia"

Tuyển tập các báo cáo nghiên cứu về sinh học được đăng trên tạp chí hóa học quốc tế đề tài : Reliability of a 1-week recall period for the Medical Outcomes Study Sleep Scale (MOS-SS) in patients with fibromyalgia | Health and Quality of Life Outcomes B Med entral Open Access Reliability of a 1-week recall period for the Medical Outcomes Study Sleep Scale MOS-SS in patients with fibromyalgia Alesia Sadosky 1 Ellen Dukes1 and Chris Evans2 Address 1Pfizer Global Outcomes Research 235 East 42nd Street New York NY 10017 USA and 2Mapi Values 15 Court Square Suite 620 Boston MA 02108 USA Email Alesia Sadosky - Ellen Dukes - Chris Evans - Corresponding author Published 10 February 2009 Received 29 August 2008 Health and Quality of Life Outcomes 2009 7 12 doi 1477-7525-7-12 Accepted 10 February 2009 This article is available from http content 7 1 12 2009 Sadosky et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Objective To evaluate the reliability of a one-week versus a four-week recall period of the Medical Outcomes Study Sleep Scale MOS-SS in patients with fibromyalgia FM . Methods The MOS-SS was administered by mail to patients with a confirmed diagnosis of FM and a current pain rating of 2 0-10 point numerical rating scale recruited through newspapers support groups and the Internet. Reliability of MOS-SS subscale domains was evaluated using test-retest methodology separated by a 1-3 day interval for the 4-week recall period and a 7-day interval for the 1-week recall period. Patient Impression of Change was evaluated for sleep and for patients with no change the intraclass correlation coefficient ICC and the Pearson correlation coefficient was calculated for MOS-SS subscales. Results Of 129 patients enrolled were female mean age was years self-rated FM severity was moderate-to-severe in of patients. MOS-SS .